文章首发于丰硕创投,欢迎朋友圈与微信转发。
公众号及其它平台转载请后台留言。
“毒物附近必有解药”,用这句话来形容肿瘤浸润淋巴细胞TIL最合适不过。在众多细胞疗法CAR-T、CAR-NK、TCR-T和TIL中,来源于肿瘤组织的TIL在对抗实体瘤的过程中已经发...查看全文
$Instil Bio(TIL)$ 8-K Current report, item 1.01 Accession Number: 0001789769-24-000075 Act: 34 Size: 157 KB 网页链接
$Instil Bio(TIL)$ 8-K Current report, item 5.07 Accession Number: 0001789769-24-000070 Act: 34 Size: 164 KB 网页链接
$Instil Bio(TIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001789769-24-000064 Size: 5 KB 网页链接
$Instil Bio(TIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001789769-24-000065 Size: 5 KB 网页链接
$Instil Bio(TIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001789769-24-000067 Size: 5 KB 网页链接
$Instil Bio(TIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001789769-24-000066 Size: 5 KB 网页链接
$Instil Bio(TIL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001789769-24-000059 Act: 34 Size: 6 MB 网页链接
$Instil Bio(TIL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001789769-24-000057 Act: 34 Size: 229 KB 网页链接
$Instil Bio(TIL)$ DEF 14A Other definitive proxy statements Accession Number: 0001789769-24-000051 Act: 34 Size: 1 MB 网页链接
$Instil Bio(TIL)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001789769-24-000052 Act: 34 Size: 2 MB 网页链接